Tata Steel – Q1 FY27 Results
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY | CNBC-TV18 Poll | Miss / Beat |
|---|---|---|---|---|---|---|---|
| Sales (₹ Cr) | 60,794 | 63,270 | ▼ 3.9% | 53,178 | ▲ 14.3% | 57,998 | ✅ Beat |
| EBITDA (₹ Cr) | 9,264 | 9,829 | ▼ 5.7% | 7,428 | ▲ 24.7% | 9,252 | 🟢 In-line / Slight Beat |
| EBITDA Margin | 15.24% | 15.54% | ▼ 30 bps | 13.97% | ▲ 127 bps | 16.00% | ❌ Miss |
| Net Profit (₹ Cr) | 2,385* | 2,965 | ▼ 19.6% | 2,007 | ▲ 18.8% | 2,391 | ❌ Miss |
| EPS (₹) | 1.86 | 2.34 | ▼ 20.5% | 1.66 | ▲ 12.0% | — | — |
Bajaj Finance – Q1 FY27 Results
| Particulars | Jun 2026 | Jun 2025 | YoY | CNBC-TV18 Poll | Miss/Beat |
|---|---|---|---|---|---|
| Net Profit (₹ Cr) | 5,986 | 4,700 | ▲ 27.4% | 5,850 | ✅ Beat |
| Net Interest Income (NII) (₹ Cr) | 12,571 | 10,228 | ▲ 22.9% | 13,102 | ❌ Miss |
| New Loans Growth | ▲ 20% | Base Period | ▲ 20% | N/A | — |
Vedanta Ltd. (Aluminium Business) – Q1FY27 Results
CMP: ₹457 | M.Cap: ₹1,78,663 Cr | P/E: 11.3
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 21,393 | 19,124 | ▲ 11.9% | 14,654 | ▲ 46.0% |
| EBITDA (₹ Cr) | 10,299 | 8,352 | ▲ 23.3% | 4,386 | ▲ 134.8% |
| Net Profit (₹ Cr) | 6,597 | 4,958 | ▲ 33.1% | 2,162 | ▲ 205.1% |
| EPS (₹) | 14.39 | — | — | — | — |
| Interim Dividend | ₹8 per equity share approved for FY27 | ||||
Verdict
Vedanta’s Aluminium business delivered an outstanding quarter with strong double-digit revenue growth and a sharp expansion in profitability. EBITDA and net profit more than doubled on a YoY basis, reflecting improved operating efficiency and healthy margin expansion. The board’s approval of an interim dividend of ₹8 per equity share further underscores strong cash generation and shareholder returns. Overall, the results indicate sustained operational strength and a positive outlook for the business.
Vedanta – Q1 FY27 Results
CMP: ₹268 | M.Cap: ₹1,04,603 Cr | P/E: 9.5
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 24,205 | 24,609 | ▼ 1.6% | 15,754 | ▲ 54% |
| EBITDA (₹ Cr) | 8,501 | 7,559 | ▲ 12.5% | 4,276 | ▲ 99% |
| Net Profit (₹ Cr) | 7,918 | 9,352 | ▼ 15.3% | 4,457 | ▲ 78% |
| EPS (₹) | 14.00 | 17.13 | ▼ 18.3% | 8.14 | ▲ 72% |
Verdict
Vedanta delivered a robust Q1 FY27 performance on a year-on-year basis, driven by strong growth in revenue, EBITDA and net profit, reflecting improved operating performance across its businesses. While earnings moderated sequentially from the exceptionally strong March quarter, profitability remained healthy with strong operating margins. The results indicate continued operational resilience and position the company well for the coming quarters.
M&M (Standalone) – Q1 FY27 Results
| Particulars | Jun 2026 | Jun 2025 | YoY | CNBC-TV18 Poll | Vs Estimate |
|---|---|---|---|---|---|
| Revenue (₹ Cr) | 41,920 | 34,083 | ▲ 23.0% | 41,764 | Beat ✅ |
| EBITDA (₹ Cr) | 5,111 | 4,884 | ▲ 4.6% | 5,281 | Miss ❌ |
| EBITDA Margin | 12.2% | 14.3% | ▼ 210 bps | 12.6% | Miss ❌ |
| Net Profit (₹ Cr) | 3,685 | 3,450 | ▲ 6.8% | 3,575 | Beat ✅ |
Management Commentary:
- Q1 tractor volumes increased 18%, ahead of expectations.
- Tractor market share stood at 44.9%, remaining strong despite a marginal decline from last year’s high base.
- Strong growth was seen across both tractors and farm machinery segments.
- Management maintained its FY27 tractor industry growth outlook at mid-single digits.
- The outlook will be reassessed after the monsoon based on the impact of El Niño.
IRB Infrastructure Developers – Q1 FY27 Results
CMP: ₹20.2 | M.Cap: ₹24,458 Cr | P/E: 24.9
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 2,137 | 1,927 | ▲ 10.9% | 2,099 | ▲ 2.0% |
| EBITDA (₹ Cr) | 1,153 | 1,083 | ▲ 6.5% | 952 | ▲ 21.1% |
| Net Profit (₹ Cr) | 306 | 296 | ▲ 3.4% | 202 | ▲ 51.5% |
| EPS (₹) | 0.25 | 0.25 | ➖ 0.0% | 0.17 | ▲ 47.1% |
Verdict
IRB Infrastructure Developers reported a strong Q1 FY27 performance, driven by robust growth in profitability and healthy operating performance. Revenue increased 2.0% YoY and 10.9% QoQ, while EBITDA rose 21.1% YoY, indicating improved operational efficiency. Net profit surged 51.5% YoY, significantly outpacing revenue growth, reflecting better margins and cost control. EPS remained flat sequentially but improved sharply on a yearly basis. Overall, the quarter highlights improving earnings quality and sustained profitability despite moderate revenue growth.
Exide Industries – Q1 FY27 Results
CMP: ₹453 | M.Cap: ₹38,484 Cr | P/E: 41.0
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 5,528 | 4,735 | ▲ 16.7% | 4,695 | ▲ 17.7% |
| EBITDA (₹ Cr) | 621 | 488 | ▲ 27.3% | 538 | ▲ 15.4% |
| Net Profit (₹ Cr) | 351 | 217 | ▲ 61.8% | 275 | ▲ 27.6% |
| EPS (₹) | 4.12 | 2.53 | ▲ 62.8% | 3.21 | ▲ 28.3% |
Verdict
Exide Industries delivered a strong Q1 FY27 performance with healthy double-digit revenue growth and a sharp improvement in profitability. Margin expansion, robust operating leverage, and strong QoQ earnings growth highlight improving business momentum and operational efficiency.
Aarti Industries Ltd – Q1FY27 Results
CMP: — | M.Cap: — | P/E: —
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Revenue (₹ Cr) | 2,387 | 2,206 | ▲ 8.20% | 1,676 | ▲ 42.42% |
| EBITDA (₹ Cr) | 382 | 343 | ▲ 11.37% | 212 | ▲ 80.19% |
| EBITDA Margin | 16.00% | 15.55% | ▲ 45 bps | 12.65% | ▲ 335 bps |
| PAT (₹ Cr) | 155 | 137 | ▲ 13.14% | 43 | ▲ 260.47% |
| Other Income (₹ Cr) | 3 | -1 | — | 4 | ▼ 25.00% |
| Exceptional Items (₹ Cr) | 2 | — | — | — | — |
Verdict
Aarti Industries delivered a strong Q1FY27 performance with healthy revenue growth, robust EBITDA expansion, significant margin improvement, and a sharp rise in profitability. The broad-based improvement across operating metrics reflects improving business momentum and stronger execution, positioning the company well for the coming quarters.
Nuvama Wealth Management Ltd – Q1 FY27 Results
CMP: ₹7,095 | Market Cap: ₹25,500 Cr | P/E: 34.6x
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Total Revenue (₹ Cr) | 1,376.22 | 1,269.11 | ▲ 8.44% | 1,122.65 | ▲ 22.59% |
| PBT (₹ Cr) | 410.52 | 355.02 | ▲ 15.63% | 350.72 | ▲ 17.05% |
| PAT (₹ Cr) | 305.64 | 268.79 | ▲ 13.71% | 263.87 | ▲ 15.83% |
| PAT After Minority Interest (₹ Cr) | 305.79 | 269.15 | ▲ 13.61% | 263.96 | ▲ 15.85% |
Verdict
Nuvama Wealth Management delivered a strong Q1 FY27 performance with healthy double-digit growth across revenue and profitability on both a YoY and QoQ basis. Revenue increased 22.59% YoY and 8.44% QoQ, while PAT rose 15.83% YoY and 13.71% QoQ, reflecting robust operating momentum, sustained client activity, and continued strength across its wealth management business.
Data Patterns (India) Ltd. – Q1 FY27 Results
CMP: ₹— | Market Cap: ₹— Cr | P/E: ₹—
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Revenue (₹ Cr) | 116.03 | 344.82 | ▼ 66.35% | 99.33 | ▲ 16.81% |
| EBITDA (₹ Cr) | 31.37 | 192.77 | ▼ 83.73% | 32.08 | ▼ 2.21% |
| PAT (₹ Cr) | 22.06 | 138.37 | ▼ 84.06% | 25.50 | ▼ 13.49% |
| Other Income (₹ Cr) | 7.31 | 5.66 | ▲ 29.15% | 10.55 | ▼ 30.71% |
Verdict
Data Patterns reported a mixed Q1 FY27 performance. Revenue grew a healthy 16.81% YoY, reflecting steady business momentum. However, profitability remained under pressure, with EBITDA declining 2.21% YoY and PAT falling 13.49% YoY. On a sequential basis, the company witnessed a sharp decline across revenue, EBITDA and PAT due to a high base in the previous quarter, indicating a soft start to FY27 despite continued top-line growth.
PSP Projects – Q1 FY27 Results
CMP: ₹951 | M.Cap: ₹3,772 Cr | P/E: 51.4
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 853 | 1,115 | ▼ 23.5% | 518 | ▲ 65.0% |
| EBITDA (₹ Cr) | 54.8 | 59.8 | ▼ 8.4% | 24.8 | ▲ 121.0% |
| EBITDA Margin (%) | 6.4% | 5.4% | ▲ 100 bps | 4.8% | ▲ 160 bps |
| Net Profit (₹ Cr) | 18.3 | 21.1 | ▼ 13.3% | 0.42 | ▲ 4,267.0% |
| Net Profit Margin (%) | 2.1% | 1.9% | ▲ 20 bps | 0.1% | ▲ 200 bps |
| EPS (₹) | 4.63 | 5.32 | ▼ 13.0% | 0.11 | ▲ 4,109.0% |
Verdict
PSP Projects delivered a strong year-on-year performance in Q1 FY27, driven by robust execution that resulted in healthy growth across revenue, EBITDA, margins, and profitability. Sequentially, however, revenue and earnings moderated from the previous quarter, reflecting a softer quarter-on-quarter performance. Despite this, the improvement in operating margins and sharp YoY earnings growth indicate that the company’s overall business momentum and execution capabilities remain healthy.
NSDL – Q1 FY27 Results
CMP: ₹823 | M.Cap: ₹16,466 Cr | P/E: 42.4
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 517 | 458 | ▲ 12.9% | 312 | ▲ 66.0% |
| EBITDA (₹ Cr) | 101 | 103 | ▼ 1.9% | 94.8 | ▲ 6.5% |
| Net Profit (₹ Cr) | 98.3 | 90.3 | ▲ 8.9% | 89.6 | ▲ 9.7% |
| EPS (₹) | 4.91 | 4.51 | ▲ 8.9% | 4.48 | ▲ 9.6% |
Verdict
NSDL delivered a strong Q1 FY27 performance with robust 66.0% YoY revenue growth, reflecting healthy business momentum. Net profit and EPS grew by around 9% both sequentially and annually, indicating stable earnings. However, EBITDA declined 1.9% QoQ, limiting margin expansion despite higher revenue. Overall, the quarter remained positive, supported by strong topline growth and consistent profitability.
Mazagon Dock Shipbuilders – Q1 FY27 Results
CMP: ₹2,319 | M.Cap: ₹93,540 Cr | P/E: 32.7
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 2,943 | 3,850 | ▼ 23.6% | 2,626 | ▲ 12.1% |
| EBITDA (₹ Cr) | 447 | 543 | ▼ 17.7% | 302 | ▲ 48.0% |
| Net Profit (₹ Cr) | 550 | 674 | ▼ 18.4% | 452 | ▲ 21.7% |
| EPS (₹) | 13.62 | 16.84 | ▼ 19.1% | 11.21 | ▲ 21.5% |
Verdict
Mazagon Dock Shipbuilders delivered a healthy year-on-year performance in Q1 FY27, with revenue, EBITDA, net profit and EPS registering double-digit growth, supported by strong execution and improved operating margins. However, sequential performance moderated across all major financial metrics following a robust Q4. Despite the softer quarter-on-quarter numbers, the company’s strong defence order book, government focus on indigenous defence manufacturing, and long-term execution pipeline continue to provide a positive outlook for sustained growth.
Pricol Ltd – Q1FY27 Results
CMP: ₹681 | M.Cap: ₹8,294 Cr | P/E: 31.0
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 1,105 | 1,099 | ▲ 0.5% | 895 | ▲ 23.0% |
| EBITDA (₹ Cr) | 124 | 131 | ▼ 5.3% | 99.0 | ▲ 26.0% |
| Net Profit (₹ Cr) | 67.0 | 73.2 | ▼ 8.5% | 49.9 | ▲ 34.0% |
| EPS (₹) | 5.50 | 6.01 | ▼ 8.5% | 4.09 | ▲ 34.0% |
Verdict
Pricol delivered a healthy year-on-year performance with strong growth in revenue, EBITDA, and net profit, reflecting robust demand and operational execution. However, on a sequential basis, profitability moderated as EBITDA and net profit declined despite largely stable revenue, indicating margin pressure during the quarter. Overall, the company’s long-term growth trajectory remains positive, supported by strong YoY earnings momentum.
DE Nora India – Q1 FY27 Results
CMP: ₹862 | M.Cap: ₹457 Cr | P/E: 37.5
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 35.3 | 22.0 | ▲ 60% | 42.0 | ▼ 16% |
| EBITDA (₹ Cr) | 5.69 | -2.27 | ▲ Turned Positive | 2.44 | ▲ 133% |
| Net Profit (₹ Cr) | 6.39 | -0.64 | ▲ Turned Positive | 3.25 | ▲ 97% |
| EPS (₹) | 12.04 | -1.21 | ▲ Turned Positive | 6.12 | ▲ 97% |
Verdict
DE Nora India reported a mixed performance in Q1 FY27. Revenue declined 16% YoY despite a strong 60% QoQ recovery. Profitability improved significantly, with EBITDA and net profit turning positive sequentially and nearly doubling compared to the same quarter last year. The sharp improvement in margins and earnings reflects a strong operational turnaround after the losses reported in the previous quarter.
Thermax – Q1 FY27 Results
CMP: ₹4,252 | M.Cap: ₹50,707 Cr | P/E: 92.1
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 2,303 | 3,428 | ▼ 32.8% | 2,158 | ▲ 7.0% |
| EBITDA (₹ Cr) | 68.6 | 374 | ▼ 81.7% | 225 | ▼ 69.5% |
| Net Profit (₹ Cr) | 21.8 | 244 | ▼ 91.1% | 151 | ▼ 85.6% |
| EPS (₹) | 2.12 | 20.50 | ▼ 89.7% | 12.79 | ▼ 83.4% |
Verdict
Thermax reported modest revenue growth of ▲ 7.0% YoY, but profitability weakened significantly during the quarter. EBITDA declined ▼ 69.5% YoY and ▼ 81.7% QoQ, while net profit plunged ▼ 85.6% YoY and ▼ 91.1% QoQ. EPS also dropped sharply by ▼ 83.4% YoY, reflecting severe margin pressure and a weak earnings performance in Q1 FY27.
Torrent Pharma – Q1 FY27 Results
CMP: ₹4,872 | M.Cap: ₹1,85,361 Cr | P/E: 83.1
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 4,921 | 4,197 | ▲ 17.2% | 3,178 | ▲ 55.0% |
| EBITDA (₹ Cr) | 1,664 | 1,356 | ▲ 22.7% | 1,032 | ▲ 61.2% |
| Net Profit (₹ Cr) | 566 | 364 | ▲ 55.5% | 548 | ▲ 3.3% |
| EPS (₹) | 16.72 | 10.76 | ▲ 55.4% | 16.19 | ▲ 3.3% |
Verdict
Torrent Pharma delivered a strong Q1 FY27 performance, with revenue rising 55.0% YoY and 17.2% QoQ, driven by healthy business momentum. EBITDA grew 61.2% YoY, leading to improved operating performance, while net profit increased 55.5% sequentially and 3.3% YoY. Overall, the quarter reflects solid execution, strong operational efficiency, and continued growth across key business segments.
Satin Creditcare Network – Q1 FY27 Results
CMP: ₹257 | M.Cap: ₹2,845 Cr | P/E: 6.9
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 762 | 920 | ▼ 17% | 703 | ▲ 8% |
| EBITDA (₹ Cr) | 417 | 599 | ▼ 30% | 357 | ▲ 17% |
| Net Profit (₹ Cr) | 123 | 162 | ▼ 24% | 45.1 | ▲ 172% |
| EPS (₹) | 11.10 | 14.67 | ▼ 24% | 4.08 | ▲ 172% |
Verdict
Satin Creditcare Network delivered a strong year-on-year performance in Q1 FY27, with net profit and EPS surging 172%, reflecting significant improvement in profitability. Revenue and EBITDA also registered healthy annual growth. However, on a sequential basis, the company reported moderation across sales, EBITDA, net profit, and EPS, indicating a softer quarter compared to Q4 FY26. Despite the QoQ decline, the robust YoY growth and healthy earnings trajectory keep the overall performance positive.
Embassy Office Parks REIT – Q1 FY27 Results
CMP: ₹438 | M.Cap: ₹41,524 Cr | P/E: 169.3
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 1,241 | 1,205 | ▲ 3.0% | 1,060 | ▲ 17.0% |
| EBITDA (₹ Cr) | 959 | 903 | ▲ 6.2% | 821 | ▲ 17.0% |
| Net Profit (₹ Cr) | 195 | -430 | ▲ Turnaround | 155 | ▲ 26.0% |
| EPS (₹) | 2.06 | -4.54 | ▲ Turnaround | 1.64 | ▲ 26.0% |
Verdict
Embassy Office Parks REIT delivered a positive Q1 FY27 performance with healthy growth in revenue and EBITDA. The REIT reported a sharp turnaround in profitability on a QoQ basis, while net profit and EPS increased 26% YoY, reflecting stronger operational performance and improved earnings momentum.
RailTel Corporation – Q1 FY27 Results
CMP: ₹294 | M.Cap: ₹9,445 Cr | P/E: 25.5
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 893 | 1,669 | ▼ 46.5% | 744 | ▲ 20.0% |
| EBITDA (₹ Cr) | 132 | 233 | ▼ 43.3% | 116 | ▲ 13.8% |
| Net Profit (₹ Cr) | 65.8 | 142 | ▼ 53.7% | 66.1 | ▼ 0.5% |
| EPS (₹) | 2.05 | 4.42 | ▼ 53.6% | 2.06 | ▼ 0.5% |
Verdict
RailTel Corporation reported a healthy 20.0% YoY growth in revenue, supported by continued execution across its telecom and digital infrastructure projects. EBITDA also increased 13.8% YoY, reflecting stable operating performance. However, net profit remained broadly flat on a yearly basis and declined sharply on a sequential basis due to a high base in the previous quarter. Overall, the quarter indicates steady operational execution with resilient revenue growth, though earnings momentum softened because of lower sequential profitability.
AWL Agri Business – Q1 FY27 Results
CMP: ₹188 | M.Cap: ₹24,381 Cr | P/E: 20.8
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 20,048 | 21,465 | ▼ 6.6% | 17,059 | ▲ 18.0% |
| EBITDA (₹ Cr) | 693 | 524 | ▲ 32.3% | 366 | ▲ 89.3% |
| Net Profit (₹ Cr) | 351 | 293 | ▲ 19.8% | 238 | ▲ 47.5% |
| EPS (₹) | 2.70 | 2.25 | ▲ 20.0% | 1.82 | ▲ 48.4% |
Verdict
AWL Agri Business delivered a strong Q1 FY27 performance with robust margin expansion and healthy profit growth despite sequential revenue moderation. The sharp improvement in EBITDA, net profit, and EPS reflects better operational efficiency, improved product mix, and enhanced earnings quality, positioning the company well for sustained growth.
Rainbow Children’s Medicare Ltd. – Q1 FY27 Results
CMP: ₹1,521 | M.Cap: ₹15,452 Cr | P/E: 53.9
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 470 | 460 | ▲ 2.2% | 353 | ▲ 33.1% |
| EBITDA (₹ Cr) | 135 | 145 | ▼ 6.9% | 104 | ▲ 29.8% |
| Net Profit (₹ Cr) | 62.5 | 78.2 | ▼ 20.1% | 53.8 | ▲ 16.2% |
| EPS (₹) | 5.96 | 7.59 | ▼ 21.5% | 5.27 | ▲ 13.1% |
Verdict
Rainbow Children’s Medicare reported a healthy Q1 FY27 performance with strong 33.1% YoY revenue growth, supported by robust business momentum across its hospital network. While EBITDA declined 6.9% QoQ and net profit fell 20.1% QoQ, the company continued to deliver double-digit YoY growth in revenue, EBITDA, net profit, and EPS. Overall, the results reflect sustained operational strength despite some sequential moderation in profitability.
Global Health (Medanta) – Q1 FY27 Results
CMP: ₹1,416 | M.Cap: ₹38,091 Cr | P/E: 66.5
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 1,304 | 1,159 | ▲ 12.5% | 1,031 | ▲ 26.0% |
| EBITDA (₹ Cr) | 287 | 244 | ▲ 17.6% | 247 | ▲ 16.2% |
| EBITDA Margin | 22.0% | 21.1% | ▲ 90 bps | 24.0% | ▼ 200 bps |
| Net Profit (₹ Cr) | 157 | 142 | ▲ 10.6% | 159 | ▼ 1.3% |
| EPS (₹) | 5.90 | 5.36 | ▲ 10.1% | 5.92 | ▼ 0.3% |
Verdict
Global Health (Medanta) delivered a healthy operational performance in Q1 FY27, with revenue rising 26.0% YoY and 12.5% QoQ, supported by strong patient volumes and hospital operations. EBITDA increased 16.2% YoY and 17.6% QoQ, while EBITDA margin improved sequentially to 22.0% but remained lower on a YoY basis. Net profit and EPS were largely stable compared to last year despite double-digit sequential growth, indicating some pressure from non-operating costs and taxes. Overall, the company maintained strong operational momentum with steady profitability, reflecting continued resilience in its healthcare business.
Niva Bupa Health Insurance – Q1 FY27 Results
CMP: ₹85.9 | M.Cap: ₹15,861 Cr | P/E: 91.0
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 2,471 | 2,251 | ▲ 9.8% | 1,932 | ▲ 28.0% |
| EBITDA (₹ Cr) | 184 | 182 | ▲ 1.1% | 98.1 | ▲ 87.6% |
| Net Profit (₹ Cr) | 138 | 159 | ▼ 13.2% | 71.4 | ▲ 93.3% |
| EPS (₹) | 0.75 | 0.86 | ▼ 12.8% | 0.39 | ▲ 92.3% |
Verdict
Niva Bupa Health Insurance delivered a strong Q1 FY27 performance, with robust premium growth driving a healthy increase in revenue and a sharp improvement in EBITDA and net profit on a year-on-year basis. While profitability remained strong compared to last year, sequential moderation in net profit and EPS indicates some near-term earnings pressure. Overall, the company’s operational momentum remains healthy, supported by continued growth in the health insurance business.
GNG Electronics – Q1FY27 Results
CMP: ₹556 | M.Cap: ₹6,328 Cr | P/E: 44.4
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 412 | 652 | ▼ 36.8% | 312 | ▲ 32.0% |
| EBITDA (₹ Cr) | 49.4 | 63.4 | ▼ 22.1% | 32.3 | ▲ 53.0% |
| Net Profit (₹ Cr) | 28.9 | 42.2 | ▼ 31.5% | 18.5 | ▲ 56.0% |
| EPS (₹) | 2.54 | 3.70 | ▼ 31.4% | 1.91 | ▲ 33.0% |
Verdict
GNG Electronics delivered strong year-on-year growth across all key financial metrics, reflecting healthy business momentum and continued expansion. However, sequential declines in revenue, EBITDA, net profit, and EPS indicate a softer quarter compared to the previous one. The long-term outlook remains positive, provided the company sustains its earnings growth and execution momentum.
JBM Auto – Q1 FY27 Results
CMP: ₹678 | M.Cap: ₹16,065 Cr | P/E: 69.8
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 1,442 | 1,852 | ▼ 22.1% | 1,254 | ▲ 15.0% |
| EBITDA (₹ Cr) | 155 | 229 | ▼ 32.3% | 120 | ▲ 29.0% |
| Net Profit (₹ Cr) | 44.3 | 83.8 | ▼ 47.1% | 39.0 | ▲ 15.0% | EPS (₹) | 1.78 | 3.14 | ▼ 43.3% | 1.56 | ▲ 14.1% |
Verdict
JBM Auto reported a mixed Q1 FY27 performance. Revenue, EBITDA, net profit and EPS registered healthy year-on-year growth, reflecting continued business expansion. However, sequential performance weakened significantly, with declines in sales, margins and profitability, indicating a softer quarter compared to Q4 FY26.
Mankind Pharma – Q1 FY27 Results
CMP: ₹2,576 | M.Cap: ₹1,06,390 Cr | P/E: 49.9
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 4,031 | 3,443 | ▲ 17.1% | 3,570 | ▲ 13.0% |
| EBITDA (₹ Cr) | 1,056 | 930 | ▲ 13.5% | 847 | ▲ 24.7% |
| Net Profit (₹ Cr) | 574 | 559 | ▲ 2.7% | 445 | ▲ 29.0% |
| EPS (₹) | 13.75 | 13.43 | ▲ 2.4% | 10.62 | ▲ 29.5% |
Verdict
Mankind Pharma delivered a strong Q1 FY27 performance with healthy double-digit revenue growth and robust profitability. EBITDA growth outpaced revenue, reflecting improved operating efficiency and margin expansion. Net profit and EPS also posted solid year-on-year gains, while sequential improvement indicates sustained business momentum. Overall, the quarter highlights resilient demand, strong execution, and continued earnings strength.
OCCL – Q1 FY27 Results
CMP: ₹158 | M.Cap: ₹783 Cr | P/E: 10.3
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 220 | 149 | ▲ 47.7% | 123 | ▲ 78.0% |
| EBITDA (₹ Cr) | 61.7 | 23.9 | ▲ 158.2% | 26.3 | ▲ 134.0% |
| Net Profit (₹ Cr) | 40.2 | 19.4 | ▲ 107.2% | 13.1 | ▲ 206.0% |
| EPS (₹) | 8.06 | 3.87 | ▲ 108.3% | 2.63 | ▲ 206.0% |
Verdict
OCCL delivered an outstanding Q1 FY27 performance with strong growth across all key financial metrics. Revenue surged 78.0% YoY, while EBITDA more than doubled with a 134.0% YoY increase, reflecting significant operating leverage and improved margins. Net profit and EPS jumped over 206% YoY, supported by robust business momentum and higher profitability. Sequentially, the company also posted impressive improvements in sales, EBITDA, net profit, and EPS, indicating sustained operational strength and a strong start to FY27.
Vinyl Chemicals – Q1 FY27 Results
CMP: ₹238 | M.Cap: ₹438 Cr | P/E: 23.4
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 99.6 | 180.0 | ▼ 44.7% | 151.0 | ▼ 34.0% |
| EBITDA (₹ Cr) | 2.68 | 2.84 | ▼ 5.6% | 1.97 | ▲ 36.0% |
| Net Profit (₹ Cr) | 6.62 | 4.65 | ▲ 42.4% | 4.45 | ▲ 49.0% |
| EPS (₹) | 3.61 | 2.54 | ▲ 42.1% | 2.43 | ▲ 49.0% |
Verdict
Despite a sharp decline in revenue both QoQ and YoY, Vinyl Chemicals reported strong growth in profitability, supported by improved margins and operational efficiency. The quarter reflects resilient earnings despite weak topline performance.
Ajanta Pharma – Q1 FY27 Results
CMP: ₹3,436 | Market Cap: ₹42,922 Cr | P/E: 37.8
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 1,626 | 1,422 | ▲ 14.3% | 1,303 | ▲ 24.8% |
| EBITDA (₹ Cr) | 424 | 333 | ▲ 27.3% | 351 | ▲ 20.8% |
| EBITDA Margin (%) | 26.1% | 23.4% | ▲ 270 bps | 26.9% | ▼ 80 bps |
| Net Profit (₹ Cr) | 334 | 267 | ▲ 25.1% | 255 | ▲ 31.0% |
| Net Profit Margin (%) | 20.5% | 18.8% | ▲ 170 bps | 19.6% | ▲ 90 bps |
| EPS (₹) | 26.75 | 21.35 | ▲ 25.3% | 20.44 | ▲ 30.9% |
Verdict
Ajanta Pharma delivered a strong Q1 FY27 performance, reporting robust double-digit growth in revenue, EBITDA, net profit and EPS on both a QoQ and YoY basis. Operating profitability improved sequentially with healthy margin expansion, while net profit margins also strengthened. Overall, the quarter reflects solid execution and sustained earnings momentum, reinforcing the company’s healthy growth trajectory.
ICRA – Q1 FY27 Results
CMP: ₹4,923 | M.Cap: ₹4,747 Cr | P/E: 24.2
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 163 | 175 | ▼ 6.9% | 124 | ▲ 31.0% |
| EBITDA (₹ Cr) | 55.1 | 69.6 | ▼ 20.8% | 39.8 | ▲ 38.4% |
| Net Profit (₹ Cr) | 56.5 | 52.7 | ▲ 7.2% | 42.8 | ▲ 32.0% |
| EPS (₹) | 58.19 | 54.35 | ▲ 7.1% | 43.97 | ▲ 32.3% |
Verdict
ICRA delivered a strong year-on-year performance in Q1 FY27, supported by healthy growth in revenue, EBITDA, net profit, and EPS. Although revenue and operating profitability moderated sequentially, the company reported higher net profit and EPS on a QoQ basis, reflecting resilient profitability and efficient cost management.
Apollo Pipes – Q1 FY27 Results
CMP: ₹496 | M.Cap: ₹2,182 Cr
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 295 | 347 | ▼ 15.0% | 275 | ▲ 7.0% |
| EBITDA (₹ Cr) | 3.05 | 18.00 | ▼ 83.1% | 20.70 | ▼ 85.3% |
| Net Profit (₹ Cr) | -11.10 | -0.13 | Loss Widened | 8.16 | ▼ 236.0% |
| EPS (₹) | -1.95 | 0.22 | Turned Negative | 1.85 | ▼ 205.0% |
Verdict
Apollo Pipes reported a weak Q1 FY27 performance. While revenue registered a modest ▲ 7.0% YoY growth, profitability deteriorated sharply due to severe margin pressure. EBITDA declined significantly on both QoQ and YoY basis, and the company slipped into a net loss with EPS turning negative. Overall, the quarter reflects a substantial weakening in operational performance despite stable topline growth.
Mahanagar Gas – Q1 FY27 Results
CMP: ₹1,118 | M.Cap: ₹11,051 Cr | P/E: 15.3
| Particulars | Jun 2026 | Mar 2026 | QoQ | Jun 2025 | YoY |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 2,372 | 2,051 | ▲ 15.6% | 2,081 | ▲ 14.0% |
| EBITDA (₹ Cr) | 343 | 260 | ▲ 31.9% | 501 | ▼ 31.5% |
| Net Profit (₹ Cr) | 194 | 132 | ▲ 47.0% | 320 | ▼ 39.4% |
| EPS (₹) | 19.61 | 13.36 | ▲ 46.8% | 32.35 | ▼ 39.4% |
Verdict
Revenue remained healthy with a 14.0% YoY increase, supported by strong volume growth. However, EBITDA and net profit declined sharply on a year-on-year basis due to margin pressure, despite a significant sequential recovery. The quarter reflects improving operational momentum compared to the previous quarter, but profitability remains below last year’s levels. Overall, the performance was mixed, with robust QoQ earnings recovery offset by weaker YoY margins and profits.
